FDA approves new St. Jude Medical defibrillators

The Food and Drug Administration okayed the Little Canada-based company's Assura portfolio of implantable cardioverter defibrillators and cardiac resynchronization therapy devices. The new line is said to have "advanced sensing options designed to reduce the incidence of inappropriate shocks."
Author:
Updated:
Original:

The Food and Drug Administration okayed the Little Canada-based company's Assura portfolio of implantable cardioverter defibrillators and cardiac resynchronization therapy devices. The new line is said to have "advanced sensing options designed to reduce the incidence of inappropriate shocks."

Next Up

police tape, crime scene

Bemidji police: 21 shots fired after 'verbal exchange' on street

Investigators say they are still searching for those responsible.

FLickr - COVID-19 vaccination - Commander, U.S. Naval Forces

As mask mandates end, vaccine disparities come to the fore

Vaccination rates in Minnesota vary widely along racial and ethnic lines.

House for sale

5 reasons things are tough for first-time homebuyers

The market for entry level homes in the Twin Cities is extremely tight.

general mills

General Mills to buy pet treats business from Tyson Foods for $1.2B

The Golden Valley company will add a number of meat treats to its portfolio.

Twin Cities Pride 3

Twin Cities Pride is going ahead in July this year – but no parade

The in-person event will be held in Loring Park in Minneapolis.

Screen Shot 2021-05-14 at 12.27.58 PM

Rejuvenation, Williams-Sonoma's furniture brand, to open first MN location

It is moving into the former Restoration Hardware unit at the Galleria in Edina.

Related

More and deeper job cuts at St. Jude Medical

The medical device maker plans another 500 job cuts, with about 100 of them in Minnesota. That follows an August round of layoffs that trimmed eighty jobs in the state. Sagging sales of defibrillators, pacemakers, and other heart rhythm devices have squeezed St. Jude and others in the industry.

St. Jude Medical to cut 300 jobs

St. Jude Medical Inc. said Thursday it is cutting 300 jobs as part of a corporate restructuring that the medical device company says will save it $50 million to $60 million annually starting next year, the Minneapolis St. Paul Business Journal reports.

St. Jude Medical says third quarter profits fell 22 percent

St. Jude Medical, Inc. reported a 22 percent drop in profits for the third quarter, MarketWatch reports. The Little Canada-based medical equipment supplier and manufacturer posted a profit of $176 million, down from $227 million a year ago.

Study links St. Jude heart wires to at least 20 deaths

Defective wires in defibrillators have caused at least 20 patient deaths, according to research in a leading cardiology journal. St. Jude stopped selling the devices in 2010 because of safety concerns but tens of thousands of people still have the implants, the AP reports. St. Jude is challenging the findings.

Minneapolis cardiologist: St. Jude defibrillator leads still problematic

Design changes to a key Little Canada-based St. Jude Medical Inc. heart device, including an added layer of insulation to reduce the risk of abrasions, do not prevent defects that could lead to device failure and death. That's according to prominent cardiologist Robert Hauser of Abbott Northwestern Hospital in Minneapolis who made the comments in a study published in the medical journal Europace. He tells the Pioneer Press, "I can't say the Durata lead is bad. I just can't say that it's good."

Mayo-developed mobile heart monitor is FDA approved

A heartbeat monitoring system that allows doctors to monitor a patient's heartbeat from a mobile device was FDA approved Monday. The device was developed by Minnesota-based Preventice in collaboration with the Mayo Clinic. Mayo cardiologists say the new technology should allow doctors to identify problems earlier by monitoring patients outside the hospital.